Overview of CRISPR/Cas system-based tumor molecular diagnostic strategies, including variant gene, protein, and liquid biopsy marker assays and in situ molecular analysis. The CRISPR/Cas system, known ...

The Point-of-Care Molecular Diagnostics Market is experiencing robust expansion driven by rising demand for rapid, accurate, ...

Cervical cancer causes approximately 350,000 global annual deaths, with 94% occurring in low- and middle-income countries. Despite decades of progress in women’s health screening, key gaps in cervical ...

Explore how oligonucleotides are reshaping therapeutics, diagnostics and CRISPR with rapid, scalable and personalized ...

Raman spectroscopy, paired with AI, offers a non-invasive method for detecting skin cancer, showing good diagnostic accuracy. Regulatory challenges and machine bulkiness limit the clinical adoption of ...

A CRISPR system detects rare cancer mutations in blood with single-nucleotide precision, outperforming ddPCR through engineered RNA guides and isothermal amplification. (Nanowerk Spotlight) Hidden ...

SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, announced today ...

Cervical cancer ranks as the fourth most common cancer among women, with hard-to-reach populations in various regions facing an increased risk of developing the disease. Preventive screening programs ...

All products featured on WIRED are independently selected by our editors. However, we may receive compensation from retailers and/or from purchases of products through these links. Learn more. At the ...